글로벌 세포 배양 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 세포 배양 시장

세포 배양 시장은 2021년부터 2028년까지의 예측 기간 동안 11.11%의 시장 성장을 목격할 것으로 예상됩니다. 세포 배양 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 세포 배양 기반 백신의 이점에 대한 인식이 높아짐에 따라 세포 배양 시장의 성장이 가속화되고 있습니다.

세포 배양은 식물이나 동물에서 세포를 제거한 후 통제된 조건 하에서 세포를 늘리는 절차로 정의할 수 있습니다.

예측 기간 동안 세포 배양 시장 성장을 촉진할 것으로 예상되는 주요 요인은 모노클로날 항체에 대한 수요 증가입니다. 나아가 세포 기반 연구에 대한 자금 지원과 일회용 기술에 대한 성향 증가는 세포 배양 시장 성장을 더욱 촉진할 것으로 예상됩니다. 나아가, 고급 세포 배양 제품의 도입과 개인 맞춤 의학에 대한 관심 증가는 세포 배양 시장 성장을 더욱 완화할 것으로 예상됩니다. 반면에 세포 생물학 연구 가격의 상승은 타임라인 기간 동안 세포 배양 시장 성장을 더욱 방해할 것으로 예상됩니다.

또한, 3D 세포 배양에 대한 필요성의 증가는 향후 몇 년 동안 세포 배양 시장 성장에 대한 잠재적 기회를 더욱 제공할 것입니다. 그러나 선진 국가의 세포 기반 연구를 위한 인프라 부족은 가까운 미래에 세포 배양 시장 성장에 더욱 큰 도전이 될 수 있습니다.

This cell culture market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cell culture market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth. 

Cell Culture Market Scope and Market Size

The cell culture market is segmented on the basis of product, application, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications. 

• On the basis of product, the cell culture market is segmented into consumables and equipment.
• On the basis of application, the cell culture market is segmented into biopharmaceutical production, diagnostics, drug screening and development, stem cell research, tissue engineering and regenerative medicine, other applications.
• On the basis of end-user, the cell culture market is segmented into pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, research institutes, cell banks.

Cell Culture Market Country Level Analysis

The cell culture market is analysed, and market size insights and trends are provided by country, product, application, and end-user as referenced above.      

The countries covered in the cell culture market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina, and rest of South America as part of South America.

North America dominates the cell culture market due to the rise in healthcare expenses. Furthermore, the increase in the elderly population will further boost the growth of the cell culture market in the region during the forecast period. Asia-Pacific is projected to observe a significant amount of growth in the decrease in the expenditure regarding stem cell transplantation. Moreover, the increasing of widespread research and development is further anticipated to propel the growth of the cell culture market in the region in the coming years.

The country section of the cell culture market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The cell culture market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the cell culture market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios, and their impact on the cell culture market. The data is available for the historic period 2010-2019.

Competitive Landscape and Cell Culture Market Share Analysis

The cell culture market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the cell culture market.

세포 배양 시장 보고서에서 다루는 주요 기업으로는 Thermo Fisher Scientific, BD, General Electric, Merck KGaA, Lonza, HiMedia Laboratories, FUJIFILM Irvine Scientific, Miltenyi Biotec, InvivoGen, Danaher, Eppendorf AG, Bio-Rad Laboratories, Inc., Corning Incorporated, Sartorius AG, PromoCell GmbH, VWR International LLC, Illumina Inc., Novogene Co., Ltd., Geneious, Advanced BioMatrix, Inc. 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-14469